Pershing Square hedge fund manager William Ackman and Valeant Pharmaceuticals CEO Mike Pearson are a match made in heaven. $1 billion in paper profits after announcement made Ackman must have pretty sweet thoughts of the relationship. After tallying nearly $1 billion in short term gain on his largest bet as a hedge fund manager – an event that took less than a few minutes as Valeant announced the acquisition of Botox marketer Allergan in after-hours trading yesterday –Ackman was all smiles with his new partner Pearson. Not a bad day’s pay for doing nothing more than providing a little muscle…
One Billion Reasons for Ackman's Love Affair With Valeant's Pearson
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.